MKI67 and breast cancer: Breast cancer is categorized into different molecular subtypes based on the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and antigen Ki-67, of which ER-positive (ER+) breast cancer is the most frequent molecular subtype (3, 4).